Recruiting
Phase 3

A Study of Baricitinib (LY3009104) in Children With COVID-19

Sponsor:

Eli Lilly and Company

Code:

NCT05074420

Conditions

Covid19

Corona Virus Infection

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

Interventions

Baricitinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2025-03-25.